These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Hyperprolactinemia: causes, diagnosis, and treatment]. Karasek M; Pawlikowski M; Lewiński A Endokrynol Pol; 2006; 57(6):656-62. PubMed ID: 17253440 [TBL] [Abstract][Full Text] [Related]
12. Guidelines for the diagnosis and treatment of hyperprolactinemia. Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814 [TBL] [Abstract][Full Text] [Related]
13. Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia. Colao A; Di Sarno A; Cappabianca P; Di Somma C; Pivonello R; Lombardi G N Engl J Med; 2003 Nov; 349(21):2023-33. PubMed ID: 14627787 [TBL] [Abstract][Full Text] [Related]
18. [Hyperprolactinemia in the postmenopause: versions and contraversions]. Leshchenko OY Ter Arkh; 2021 Oct; 93(10):1234-1239. PubMed ID: 36286827 [TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia/Prolactinomas in the Postmenopausal Period: Challenges in Diagnosis and Management. Pekić S; Medic Stojanoska M; Popovic V Neuroendocrinology; 2019; 109(1):28-33. PubMed ID: 30347396 [TBL] [Abstract][Full Text] [Related]
20. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists. López JM; Oestreicher E Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]